Spectrum Pharmaceutecals Inc (SPPI)

[antihama]

Spectrum Pharmaceuticals Highlights Four Abstracts at the 58th Annual Meeting of the American Society of Hematology (ASH) in San Diego, California, December 3-6, 2016

December 2, 2016
HENDERSON, Nev.--(BUSINESS WIRE)--Spectrum Pharmaceuticals (SPPI), a biotechnology company with fully integrated commercial and drug development operations with a primary focus in Hematology and Oncology, today announced key presentations of clinical and scientific data related to its products at the 58th Annual Meeting of the American Society of Hematology (ASH), being held in San Diego, California, from December 3-6, 2016.
For more information about the ASH annual meeting and for a complete list of abstracts, please refer to the conference website at https://ash.confex.com/ash/2016/webprogram/start.html.
The following are key PTCL-related abstracts being presented at the ASH meeting:
Abstract # Type Title First Author Date/Time
Location
4149 Poster Case Match Control Analysis of Propel Reveals Survival Advantage for Patients with Relapsed/Refractory (R/R) Peripheral T-Cell Lymphoma (PTCL) Treated with Pralatrexate O’Connor Monday, Dec 5,
6:00 PM-8:00 PM
Hall GH
4150 Poster Differential Outcome of Patients with Primary Refractory Vs. Relapsed Peripheral T-Cell Lymphoma: Analysis from a Prospective Multicenter US Cohort Study Lansigan Monday, Dec 5,
6:00 PM-8:00 PM
Hall GH
1824 Poster The Pralatrexate - Romidepsin Doublet: A Well Tolerated and Highly Effective Combination for Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma Amengual Saturday, Dec 3,
5:30 PM-7:30 PM
Hall GH

The following key ZEVALIN® (ibritumomab tiuxetan)-related abstract will be presented at the ASH conference:
Abstract # Type Title First Author Location
1793 Poster Short Course of Bendamustine and Rituximab Followed By 90Y-Ibritumomab Tiuxetan in Patients with Chemotherapy-Naive Follicular Lymphoma (FOL-BRITe): Final Report of Response Rates and Progression Free Survival Costa Saturday, Dec 3,
5:30 PM-7:30 PM
Hall GH